Related Experiment Video
Updated: Aug 10, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Mortality and Complications of COVID-19 Among Adult Congenital Heart Disease Patients: A Retrospective Cohort Study
Kavin Raj1, Vrinda Vyas1, Karthik Yeruva2
1Division of Cardiology, Department of Medicine, University of California Riverside School of Medicine, Riverside, CA.
Insights
Adult congenital heart disease (ACHD) patients with COVID-19 face higher risks of in-hospital death and severe illness. Preventive care, including vaccination, is crucial for improving survival in this vulnerable population.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Adult congenital heart disease (ACHD) is a growing population with unique health vulnerabilities.
- The impact of COVID-19 on ACHD patients requires specific investigation due to potential complications.
Purpose of the Study:
- To determine in-hospital mortality and complicated COVID-19 infection rates in ACHD patients.
- To identify specific ACHD subtypes and risk factors associated with adverse COVID-19 outcomes.
Main Methods:
- Utilized the National Inpatient Sample (NIS) database.
- Analyzed data from 4219 COVID-19 patients with ACHD.
- Conducted subgroup analyses for specific congenital heart defects.
Main Results:
- ACHD patients with COVID-19 had significantly higher in-hospital mortality (OR 1.04) and complicated infections (OR 1.30).
- Tetralogy of Fallot (TOF) was linked to higher mortality, while atrial septal defects (ASD) correlated with more complicated infections.
- Advanced age, lower income, unrepaired ACHD, malnutrition, and chronic liver disease were mortality risk factors.
Conclusions:
- COVID-19 poses a significant threat to ACHD patients, increasing mortality and complication risks.
- Targeted preventive strategies, including vaccination and non-pharmacologic measures, are recommended for ACHD patients to enhance survival rates.
Abstract:
This study examines in-hospital mortality and complicated COVID-19 infection among adult congenital heart disease (ACHD) patients admitted with COVID-19, using the National Inpatient Sample (NIS). A total of 4219 COVID-19 patients with ACHD were included. We demonstrated that COVID-19 patients with ACHD were more likely to experience in-hospital mortality (OR 1.04, 95% CI 1.04-1.04, P < 0.01) and complicated COVID-19 infection (OR: 1.30, 95% CI: 1.11-1.53, P < 0.01). In our sub-group analysis, COVID-19 patients with tetralogy of Fallot (TOF) had higher mortality and COVID-19 patients with atrial septal defects (ASD) had a higher incidence of complicated infection when compared to COVID-19 patients with all other ACHDs. Risk factors for mortality among COVID-19 patients with ACHD include advanced age, lower income, unrepaired ACHD, malnutrition, and chronic liver disease. Accordingly, we recommend aggressive preventive care with vaccination and non-pharmacologic measures in order to improve survival for ACHD patients.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Pneumonia III: Complications and Assessment
Cardiac Catheterization I: Pre-Procedure Overview
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation I: Adult
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: